Emerging targeted agents in the field of mastocytosis

Tracy George, MD, The University of Utah, Salt Lake City, UT, outlines the current treatment landscape of systemic mastocytosis as well as emerging agents in this field, including novel anti-KIT approaches currently in evaluation in this patient population. This interview took place at the virtual American Association for Cancer Research (AACR) Annual Meeting 2021.